(Q50580767)

15 March 2018

title

Oxidative status in chronic hepatitis C: the influence of antiviral therapy and prognostic value of serum hydroperoxide assay (English)

1 reference

15 March 2018

1 reference

Filomena Morisco

1

1 reference

15 March 2018

Veronica Verde

2

1 reference

15 March 2018

Vincenzo Fogliano

3

1 reference

15 March 2018

Alberto Ritieni

4

1 reference

15 March 2018

Riccardo Marmo

5

1 reference

15 March 2018

Giusy De Luise

6

1 reference

15 March 2018

Concetta Tuccillo

7

1 reference

15 March 2018

Nicola Caporaso

8

1 reference

15 March 2018

publication date

1 June 2004

1 reference

15 March 2018

published in

Free Radical Research

1 reference

15 March 2018

volume

38

1 reference

15 March 2018

issue

6

1 reference

15 March 2018

page(s)

573-580

1 reference

15 March 2018

Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups

cites work

1 reference

https://api.crossref.org/works/10.1080%2F10715760410001688357

Oxidative stress-related molecules and liver fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760410001688357

Low serum retinol levels are associated with hepatocellular carcinoma in patients with chronic liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760410001688357

Superoxide dismutase in patients with chronic hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760410001688357

Mitochondrial injury, oxidative stress, and antioxidant gene expression are induced by hepatitis C virus core protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760410001688357

Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760410001688357

Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C. International Hepatitis Interventional Therapy Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760410001688357

Iron storage, lipid peroxidation and glutathione turnover in chronic anti-HCV positive hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760410001688357

Hemolytic anemia induced by ribavirin therapy in patients with chronic hepatitis C virus infection: role of membrane oxidative damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760410001688357

Use of N,N-dimethyl-p-phenylenediamine to evaluate the oxidative status of human plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760410001688357

Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760410001688357

Hepatitis C virus proteins: direct link to hepatic oxidative stress, steatosis, carcinogenesis and more

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760410001688357

Oxidative stress in chronic hepatitis C: not just a feature of late stage disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760410001688357

Oxidative stress in symptom-free HCV carriers: relation with ALT flare-up.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760410001688357

Alpha-glutathione transferases in HCV-related chronic hepatitis: a new predictive index of response to interferon therapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760410001688357

N-acetyl cysteine enhances the response to interferon-alpha in chronic hepatitis C: a pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760410001688357

Interferon/antioxidant combination therapy for chronic hepatitis C--a controlled pilot trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760410001688357

Association between reactive oxygen species and disease activity in chronic hepatitis C

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760410001688357

Role of glutathione, lipid peroxidation and antioxidants on acute bile-duct obstruction in the rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760410001688357

Evidence for accelerated generation of hydroxyl radicals in experimental obstructive jaundice of rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760410001688357

The flavonoid quercetin ameliorates liver damage in rats with biliary obstruction

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760410001688357

10.1080/10715760410001688357

21 January 2018

Identifiers

DOI

1 reference

15 March 2018

1 reference

15 March 2018